Biopharma Companies Worldwide
Location
Category
List of Biopharma companies in All locations
859 companies
Sort by
We empower researchers across immunology and oncology with the precision tools they need to unlock critical cellular insights.
Founded by a team of seasoned experts with decades of experience in both industry and academia, InnoCyto is committed to delivering reliable, consistent reagents that accelerate scientific discovery. Our dedication to quality and innovation makes us a trusted partner for laboratories worldwide.
We specialize in developing the SonoMatrix platform, a compact and scalable system that utilizes sonication to rapidly and reproducibly process biological samples in plate-scale formats. Our technology is designed to streamline workflows for applications like Next-Generation Sequencing (NGS) and epigenetic analysis, reducing hands-on time and improving consistency.
Triangle Biotechnology’s expertise combines advanced acoustics engineering with molecular biology, allowing us to create custom mechanical sample-prep workflows tailored to specific customer needs. We are dedicated to making high-throughput sample preparation accessible and affordable globally, supporting the evolving demands of the life sciences industry.
Founded in 2019, Triangle Biotechnology currently employs a team of six experts and is headquartered in Durham, North Carolina.
We leverage our expertise in translational biochemistry and stem cell technology to create next-generation treatments, including engineered exosomes for skin care, joint care, and other therapeutic applications. Our core focus is on developing a revolutionary bioscience device that mimics the function of a healthy pancreas, offering a continuous and controlled insulin delivery system without the need for injections or traditional monitoring.
XOStem’s commitment to rigorous research, validated by scientific institutions and university partnerships, positions us at the forefront of exosome science and personalized medicine. We are dedicated to improving lives through groundbreaking advancements in regenerative therapies, initially targeting companion animals before expanding to human applications.
We provide robust, diverse enrollment, quality data, and responsive communication to sponsors and CROs, ensuring the smooth initiation and execution of early through late phase clinical trials.
Founded by Dixie L. Creager, a seasoned multi-location manager with over 30 years of experience, Exalt Clinical Research combines progressive recruitment practices with compassionate patient care. Our team, led by Dr. Tiffany Deal Hecklinski and Niki Estrada, brings a wealth of expertise in communication, recruitment, and patient advocacy, driven by a commitment to advancing medical science.
Exalt Clinical Research is committed to digitalized processes combined with compassionate patient care resulting in a streamlined data collection model and efficient study execution.
We engineer and sell pennycress seeds – a winter oilseed crop – enabling farmers to increase profits and simultaneously bolster ecosystem health.
By utilizing state-of-the-art technologies in plant science, including gene editing and metabolic modeling, we’re creating a sustainable solution for farmers and a valuable feedstock for renewable fuels like biodiesel and sustainable aviation fuel. Our approach connects the supply chain from the field to biorefineries, supporting a low-carbon future for the agricultural industry. Pennycress offers a unique opportunity to enhance soil health, sequester carbon, and diversify farm income.Bioengineering and sustainable aviation fuel are key components of our mission.
We address some of the most challenging unmet healthcare needs by creating highly effective and targeted therapies. Our approach, which differs significantly from traditional pharmaceutical methods, avoids genome encoding, focusing instead on the structural properties of RNA.
Helixomer’s innovative technology, combined with a dedicated team of experts, is driving advancements in precision medicine and offering a new paradigm for drug development. We are committed to delivering impactful solutions for healthcare heroes.
We are developing Hybrid Neutrophils, a first-in-class autologous cell therapy that dramatically enhances the effectiveness of therapeutic antibodies in solid tumors.
Our platform centers on naturally occurring Hybrid (APC-like) Neutrophils, discovered at the University of Pennsylvania, which combine potent cytotoxicity with professional antigen presentation, directly killing tumor cells and activating adaptive immunity.
Hybrid Biotherapeutics is led by a multidisciplinary team of experts in immunology, cell therapy, and oncology, with a proven track record of advancing complex biologics. We are currently focused on EGFR-positive colorectal cancer (CRC) and EGFR-mutated non-small cell lung cancer (NSCLC), with broad expansion potential across antibody-addressable solid tumors.
With the global population projected to reach 10 billion by 2050, Upstream Biotechnology addresses the urgent need for increased agricultural productivity in the face of climate change and evolving food security challenges.
Our patented SwitchBlade Technology utilizes natural RNA-based solutions to modulate plant immunity, providing broad-spectrum resistance against diseases and abiotic stresses – all without compromising yield. We are focused on partnering with seed companies to deliver next-generation traits that enhance grower profitability and build resilience across the value chain.
Upstream Biotechnology is currently developing a pipeline of traits for key crops, including soy, and actively seeking collaborations for field trials and commercialization.
We specialize in providing secure, long-term sample storage solutions for the life sciences industry, supporting researchers and pharmaceutical companies with their critical data needs.
Lab Vendor distinguishes itself through our commitment to regulatory compliance, comprehensive cold storage equipment offerings – including ULT freezers, laboratory refrigerators, and cryogenic systems – and dedicated support services, encompassing installation, preventative maintenance, and repair. We’re dedicated to ensuring reliable and continuous operation of your vital research infrastructure.
With a nationwide network of strategically located facilities, we offer scalable and flexible storage options to meet the evolving demands of the scientific community.
We design natural or synthetic microbes or microbial consortia to solve complex biological problems. Our flagship product, Extremase, is a proprietary enzyme cocktail that converts non-food plant waste to sugar for ethanol fermentation and biorefining.
What sets MTE apart is our expertise in leveraging non-model biology – studying organisms from harsh environments – to adapt them for industrial applications. We’re focused on creating sustainable solutions for the agricultural and energy sectors, reducing waste, and improving resource utilization. We offer solutions for increasing the rate of anaerobic digestion, the yield of biogas, and for co-production of high-value renewable hydrocarbons.
Founded in 2024, MTE is driven by a team of experienced scientists and engineers dedicated to translating cutting-edge research into real-world solutions. We are committed to fostering a circular bioeconomy and supporting a more sustainable future.
We investigate the complex interactions within microbial communities, focusing on how environmental variables influence their behavior and developing metrics to guide the creation of new collective behaviors. Our research leverages cutting-edge techniques including microfluidics, massively parallel microscopy, and machine learning to understand and manipulate these interactions.
Oliveira Lab’s work supports advancements in areas such as agriculture, biopharma, and industry, with a particular emphasis on shifting microbiome metabolic states and exploring the spatiotemporal behavior of biological networks. We are dedicated to fostering innovation in synthetic biology and creating tools for a more sustainable future.
We focus on creating a revolutionary CYPREX platform, utilizing our patented poly(ester urea) technology to engineer tunable degradation and controlled drug release. This technology addresses critical unmet needs across a range of clinical applications, including regenerative medicine and advanced drug therapies.
Viamer Biosciences is dedicated to advancing the field of bioresorbable technologies, offering a unique approach to improving patient outcomes and therapeutic efficacy. Our commitment to precision and innovation positions us as a leader in the development of next-generation medical devices. Founded in 2017, we are a privately held company with a growing team dedicated to transforming healthcare through advanced biomaterials.
We specialize in supporting leading organizations – including biotech, pharmaceutical, and contract research – in navigating complex regulations and ensuring adherence to GCP, GLP, and cGMP standards. Our experienced consultants deliver comprehensive solutions, encompassing GCP, GLP and cGMP training, quality assurance audits, compliance training, clinical audits, vendor audits, batch record review, SOP writing, and quality systems implementation.
Founded in 2009, ComplianceLogix leverages a global network of seasoned professionals to help clients achieve operational excellence and meet stringent regulatory requirements. We’re dedicated to translating complex regulations into practical, sustainable solutions, ultimately contributing to the development of innovative and life-saving therapeutics.
We provide comprehensive solutions for researchers and clinical trials, managing Leukopaks and purified cells with meticulous quality control from procurement to cryopreservation.
CellSEP distinguishes itself through our extensive donor database, advanced flow cytometry capabilities, and a dedicated team committed to accelerating your research. We offer a robust suite of services, including PBMC processing, cell separation, and clinical trial study support, all backed by 24/7 temperature monitoring and secure logistics.
With locations across the US – Charleston, Austin, Atlanta, Dallas-Fort Worth, and Orlando – and a commitment to innovation, CellSEP is your trusted partner in advancing life sciences.
We’re revolutionizing farm resiliency by harnessing strategies learned from the COVID-19 pandemic, providing near real-time monitoring and analysis to detect, forecast, and prevent diseases – safeguarding livestock health, productivity, and biosecurity.
DARO’s approach combines population genetics, microbiology, and swine medicine with a deep understanding of technology startups, offering a truly unique and proactive solution. Our system empowers farmers to make informed decisions, minimizing disease spread and maximizing herd performance.
Founded in 2023, DARO is committed to delivering fast, accurate, and barn-wide disease intelligence, stopping outbreaks early and protecting the livelihoods of livestock producers.
We are dedicated to advancing a differentiated pipeline of small molecules and bioligand-tag conjugates, leveraging Astatine-211 (211At), Iodine-131 (131I), and Fluorine-18 (18F) to deliver exquisitely matched therapies.
Our proprietary chemistry, including stabilized carbon-halogen bonds, enables accurate dosimetry, improved patient stratification, and reduced off-target toxicity. dGenThera’s technology offers a significant advancement in targeted radiotherapy, with promising results demonstrated in preclinical studies, including tumor growth inhibition in breast cancer xenograft models. We are committed to transforming cancer treatment through innovative, safe, and effective radiotherapeutics.
We provide children with recreational prosthetic devices designed with 3D printing, fostering a sense of belonging and empowering them through inclusive events and educational resources.
At the heart of our mission is a diverse team of students, community members, and partners, working collaboratively to create innovative solutions and build a supportive network. Our seven collegiate chapters – UNC Chapel Hill, UNC Charlotte, NC State, and Durham Tech – specialize in customized designs, elbow-driven devices, and creative comfort, ensuring that each child receives a uniquely tailored and empowering experience.
The Helping Hand Project is a registered 501(c)(3) nonprofit, committed to making a tangible difference in the lives of children with limb differences and their families.
We are dedicated to addressing the significant unmet medical needs of patients facing challenging diagnoses such as glioblastoma, brain metastases, and atypical teratoid rhabdoid tumors (ATRT). Our research focuses on **precision oncology**, leveraging AI-powered innovation to identify and develop targeted treatments.
Starlight Therapeutics is currently focused on advancing our lead drug candidate, STAR-001, through **clinical trials** and preclinical development, with the goal of significantly improving patient outcomes in these devastating diseases.
We are a rapidly growing team of scientists and clinicians committed to lighting the way in **brain and CNS cancer treatment**.
We are pioneering first-in-class adenosine-based therapies designed to reverse bone loss, accelerate bone repair, and improve healing outcomes across a range of conditions including osteoporosis, fracture healing, spinal fusion, and orthopedic surgery.
Our technology, stemming from research at Duke University, utilizes a unique platform to promote and accelerate bone regeneration while simultaneously reducing pain. Backed by promising preclinical data, OsteoCure is redefining the treatment landscape for bone health and injury.
We are committed to translating our research into impactful therapies that improve the lives of patients worldwide.
We provide a comprehensive range of products, including bioactive recombinant proteins, validated antibodies, and in vitro use immunoassay products, catering to the needs of biomedical researchers and diagnostic companies globally.
BioTimes is dedicated to supporting innovation and discovery within the life sciences industry through our commitment to quality and reliable service. We offer CRO services and GMP manufacture to accelerate your research and development timelines.
Established in March 2020, BioTimes Inc. currently employs a team of 4 professionals, focused on delivering exceptional value to our customers worldwide.
We empower researchers to identify the precise molecular causes of disease with unparalleled accuracy. Our core offering, the **Phaeno tools**, provides a platform for rapid and reliable analysis of complex genomic data, accelerating the discovery of novel biomarkers and diagnostic targets.
Designed for laboratories and research institutions, our tools streamline workflows and enhance the precision of disease diagnosis and treatment. We are dedicated to advancing scientific discovery through cutting-edge genomic technology.
Phaeno Biotech was founded with the mission to transform the landscape of biomedical research, and we continue to expand our capabilities to meet the evolving needs of the scientific community.
We provide a cutting-edge platform that integrates diverse biological data – genomics, transcriptomics, proteomics, and imaging – to reveal intricate spatial relationships within cells and tissues. This allows researchers and clinicians to gain unprecedented insights into disease mechanisms and identify novel therapeutic targets.
Our platform empowers scientists to accelerate drug discovery, improve diagnostics, and ultimately, deliver more effective and personalized treatments. We are dedicated to supporting the next generation of biological innovation, offering a powerful tool for those seeking to unlock the complexities of life.
Arvetas Biosciences is committed to driving progress in **biotechnology research** and contributing to a future where healthcare is tailored to the individual.
MuriPhys offers a comprehensive suite of services, including precise CNS and systemic drug product delivery, rodent model characterization, and expertise in a wide range of disease indications – from pain disorders and substance abuse to neurodegenerative and neuropsychiatric conditions.
As an AAALAC-accredited CRO with a fully functional rodent vivarium and licensed DEA controlled substances, Muriphys is dedicated to accelerating your research. We partner with small and mid-sized biotech companies, providing tailored preclinical development, pharmacology, toxicology, and data analysis solutions to support your specialized needs and drive impactful preclinical discovery.
We’re dedicated to transforming the food industry through innovative biotechnology and bioengineering, creating delicious and nutritious alternatives to traditional meat sources. Our cultivated meat technology offers a sustainable and ethical solution for consumers and the planet.
Atelier Meats is focused on developing cultured meat that is both tasteful and competitively priced, addressing the growing demand for sustainable protein. We are committed to advancing the future of food through rigorous scientific research and development.
As a rapidly growing company with a team of experts, Atelier Meats is at the forefront of the biotechnology research sector, driving innovation in the cultivated meat space.
We provide the Çava Seat™, a smart toilet seat equipped with advanced sensors and artificial intelligence, to deliver continuous, non-invasive health insights.
Çava’s technology analyzes key biomarkers in stool samples – including gut health, heart health, fitness levels, and hygiene – providing users with actionable data to optimize their lifestyle and proactively manage their well-being. Our AI-powered platform translates complex data into simple, understandable recommendations, empowering individuals to take control of their health journey.
Founded in 2019, Çava is committed to making preventive healthcare accessible and affordable for everyone, shifting the focus from reactive treatment to proactive wellness. We’re dedicated to building the future of personalized health monitoring, one seat at a time.
We are dedicated to addressing significant unmet medical needs in autoimmune and inflammatory diseases, such as rheumatoid arthritis, chronic pain, and systemic sclerosis. Our core focus is on TAK1 inhibitors, a novel class of drugs designed to provide safer and more effective treatments by targeting inflammation at its source.
EydisBio’s proprietary inhibitors represent a significant advancement in therapeutic approaches, offering locally-acting, orally bioavailable solutions with the potential to overcome immune-induced therapy resistance. We are currently conducting in vivo efficacy and pilot safety studies, exploring applications beyond RA, including viral-induced ARDS and chronic pain management.
Founded by Dr. Timothy Haystead, a seasoned biotechnology leader with extensive experience in small molecule discovery, EydisBio is committed to translating innovative research into tangible benefits for patients.
We provide a vital platform for laboratory animal science professionals across the Research Triangle region – including technicians, researchers, vendors, and students – to connect, grow, and lead in their fields. Through a diverse range of events, such as technical workshops, social gatherings, and our annual Awards Banquet, we foster a thriving community of experts.
RTB AALAS distinguishes itself through its commitment to education, training, and professional development, empowering individuals to uphold the highest standards of animal welfare. We are a cornerstone of the laboratory animal science community in North Carolina, supporting innovation and ethical practices.
Based in Orlando, Florida, we focus on the discovery and advancement of natural remedies for invasive diseases. Our team of scientists and researchers are dedicated to harnessing the power of phytotherapy to develop innovative treatments.
US Phytotherapy, Inc. provides high-quality, scientifically-backed ingredients to the pharmaceutical and nutraceutical industries. We are committed to sustainable practices and rigorous quality control, ensuring the efficacy and safety of our products.
Founded in 2008, we operate with a core mission to improve human health through the responsible use of botanical resources.
Our core service is accelerating medical discovery by enabling the functional analysis of the entire genome. We empower scientists to investigate endogenous proteins with greater speed and precision, significantly reducing the time and resources required for traditional research methods.
CasTag Biosciences leverages technology developed at Duke University, offering a unique solution for those seeking to unlock the full potential of genomic research. We are dedicated to providing cutting-edge tools and support to the global research community, driving innovation in areas such as drug development and personalized medicine.
Founded on groundbreaking scientific advancements, CasTag Biosciences is rapidly establishing itself as a leader in gene analysis, with a growing team of experts committed to advancing the frontiers of biomedical research.
NeuroSpire’s platform provides associates with an accessible and affordable way to conduct advertising testing and packaging testing, enabling data-driven decisions across various industries.
Our technology streamlines the process of neuromarketing research, offering a significant advantage to companies seeking to understand consumer preferences and optimize their marketing strategies. We are dedicated to making advanced neuroscience accessible to a wider range of businesses.
Founded in 2010, NeuroSpire has rapidly grown to become a trusted partner for organizations looking to leverage the power of neuromarketing, with a team of experts and a commitment to continuous innovation.
We focus on the discovery and development of novel therapies for conditions like post-bariatric hypoglycemia and gastroparesis, addressing significant unmet needs in metabolic and gastrointestinal disease management. Our lead compound, mizagliflozin, is a promising oral drug candidate designed to reduce postprandial glucose absorption and mitigate insulin and gastric inhibitory peptide (GIP) secretion.
Vogenx leverages state-of-the-art technology and a team of experienced professionals to advance our pipeline and deliver innovative solutions. We are committed to transforming the lives of patients with rare diseases through scientific innovation and dedicated research.
We are harnessing the power of virus-like particle (VLP) vaccines to eliminate senescent cells, one of the fundamental drivers of aging and chronic disease. Our immunotherapy offers a unique approach to reversing established plaque formation and restoring natural tissue function, moving beyond simply slowing the decline associated with cardiovascular disease.
What sets Vertical Longevity apart is our platform’s ability to target senescent cells durably, enabling a vaccine-mediated immune response that clears these cells and offers potential benefits across multiple organ systems – including pulmonary, renal, neurological, and structural tissues.
Currently, we are focused on confirming efficacy in upcoming primate studies, with the goal of demonstrating the first true cure for atherosclerosis. We are positioned at the intersection of cardiovascular, senolytic, and longevity markets, offering a cost-competitive intervention with the potential to redefine preventive care at a population level.
We are dedicated to addressing the growing global challenge of conditions like Alzheimer’s Disease and Mild Cognitive Impairment (MCI). Our core research and development efforts center around RIV-5061, a novel drug candidate designed to target the underlying mechanisms of cognitive impairment.
Revivo Therapeutics leverages a proprietary platform to identify and develop targeted therapies, offering a potential new approach to treating debilitating neurological conditions. We are currently seeking funding to support Phase 1/1b clinical trials, bringing our promising drug candidate closer to patients.
Founded in 2016, Revivo Therapeutics is comprised of a dedicated team of scientists and experts committed to transforming the landscape of cognitive health.
We are pioneering the development of peptide therapeutics – specifically, innovative treatments designed to be faster, more effective, and safer than traditional antidepressants and anxiolytics. Our research targets key biological pathways involved in mood disorders, offering a potentially transformative approach to patient care.
Akhu Therapeutics is dedicated to addressing the significant unmet needs in the mental health space, leveraging cutting-edge biotechnology to create impactful therapies. We are committed to advancing the science of peptide therapeutics and improving the lives of individuals and animals affected by these conditions.
Founded in 2015, Akhu Therapeutics currently employs a small team of dedicated scientists and researchers, driven by a passion for innovation and a commitment to delivering life-changing medicines.
We support reference labs, hospitals, and pharmaceutical companies by expertly handling esoteric and small-volume testing needs, including sample extraction and the development of novel tests.
Our commitment to rapid turnaround times, enhanced quality control, and collaborative development ensures our clients receive reliable and innovative solutions. We offer a comprehensive testing menu and specialize in assay validation and modification, as well as the creation of new assays.
Founded in 2013, Pan Laboratories has grown to a team of 6, dedicated to providing exceptional service and scientific expertise. We are focused on delivering competitive pricing and tailored solutions to meet the unique demands of our clients.
We develop OrganRX™, the world’s first gravity-driven multiorgan system, revolutionizing in vitro biomedical research for drug discovery, disease pathology, and regenerative medicine.
Biopico’s OrganRX system accurately recapitulates human physiology by engineering physiological fluidic flow and organ microenvironments, offering a truly human-on-a-plate model.
Founded in 2014, Biopico Systems is dedicated to advancing human health through physiologically relevant models, accelerating the development of life-saving therapies. Our OrganRX™ Plate, System, and CRO services provide researchers with the tools and expertise to tackle complex challenges in drug development and disease modeling.
We empower vision professionals to deliver improved clinical outcomes and engaging therapeutic experiences to patients with binocular vision disorders. Our core offering, VERVE, is an FDA-cleared VR device specifically designed for the treatment of convergence insufficiency, while SPOT, launching in 2026, will provide a rapid screening platform for a wide range of binocular disorders.
Founded in 2018 by a team of vision scientists, engineers, and optometrists, OculoMotor Technologies leverages cutting-edge technology to transform the way vision care is delivered, making it more accessible, efficient, and enjoyable for both patients and practitioners. We are committed to advancing the field through rigorous research and development.
Our technology offers a significant advancement in cancer diagnostics, moving beyond traditional methods to detect the disease at its earliest stages – often before symptoms appear.
Nexosome’s platform is designed for use in clinical settings, providing physicians with a powerful tool for personalized cancer care and improved patient outcomes. We are focused on transforming cancer diagnostics and ultimately saving lives.
Nexosome Oncology is committed to innovation and has secured key patents in the field of extracellular vesicle analysis. We are rapidly expanding our capabilities and partnerships to bring our groundbreaking technology to market.
We focus on improving the management of both severe acute diseases, such as sepsis, and chronic conditions like diabetes. Clinical Sensors leverages bioanalytical electrochemistry and biocompatible coatings to create advanced sensor technologies.
Founded in 2014 and backed by significant NIH and State of North Carolina awards, Clinical Sensors is dedicated to translating cutting-edge research into impactful healthcare solutions. We are the second company originating from Professor Mark Schoenfisch’s lab at the UNC-Chapel Hill Department of Chemistry.
Our commitment to innovation and patient outcomes drives our mission to transform healthcare through advanced sensing technologies.
We bring a unique perspective to the recruitment process, leveraging our decades of experience as former executives and hiring managers across Biotech, Diagnostics, Healthcare Tech, and other industries. Our team has successfully built and led companies, managed teams of over 100 employees, and developed specialized departments – from Sales Expansions to E-Commerce Teams – consistently delivering exceptional results.
What sets Tenure apart is our deep understanding of what it takes to build a thriving organization and our commitment to finding candidates who not only possess the right skills and experience but also align with your company’s culture, values, and long-term goals. We focus on intangible qualities like commitment, chemistry, and credibility to ensure a truly successful hire.
As a result, we prioritize candidates with tenure in their previous roles and only recommend individuals who have a genuine desire to contribute to your organization’s success. We are dedicated to providing a recruitment process that is experienced, efficient, and ultimately successful in securing the right individuals who will continuously drive your business forward.
We address a critical bottleneck in the cell therapy field – the slow and costly iteration cycle – by automating the process and leveraging artificial intelligence. Our platform dramatically reduces development timelines, moving from months to days, allowing researchers to explore and optimize cell therapies with unprecedented speed and efficiency.
CellEcho’s core technology, a fully automated platform, is transforming the landscape of immunooncology, regenerative medicine, and other cell therapy applications. We are building the world’s fastest, smartest engine for creating living medicines, ultimately improving patient outcomes and accelerating the delivery of life-saving treatments.
Founded in 2021, CellEcho Biotech is comprised of a dedicated team focused on pioneering advancements in cell engineering and cell therapy automation.
Our mission centers on tackling Limb-Girdle Muscular Dystrophy Type 2B/R2 (LGMD 2B/R2), a debilitating condition affecting muscle function, driven by a deep understanding of the disease’s origins – the founder’s personal experience as a patient and his family.
We leverage cutting-edge stem cell therapy and gene-editing technologies, supported by the FDA’s regulatory framework for individualized medicine, to create innovative solutions. Beyond LGMD 2B/R2, we are committed to expanding our research platform to address a broader spectrum of rare genetic disorders, offering hope to patients and families worldwide.
Our proprietary platform technology, proven effective in surface, water, and airborne applications, offers a powerful approach to disinfection and cleaning. We focus on creating eco-friendly products utilizing natural and common ingredients, mirroring the safety and efficacy found in baby products and everyday foods.
BioNeutral Group’s solutions cater to a range of industries requiring advanced decontamination, including industrial hygiene, healthcare, and environmental services. We are dedicated to providing effective and sustainable solutions for a cleaner, safer world.
We are dedicated to enabling life-changing gene therapies by providing a revolutionary solution to combat harmful antibody responses. Our core technology instantly blocks all detrimental antibody reactions, unlocking the full potential of cutting-edge treatments for patients battling rare diseases.
NabGen’s approach focuses on providing a critical barrier against the immune system’s interference, allowing gene therapies and organ transplants to proceed effectively. We are committed to accelerating the development and delivery of these vital medical advancements, ultimately improving patient outcomes and extending lives.
NabGen Inc. was founded to address a significant hurdle in the field of gene therapy, and we are rapidly scaling our operations to meet the growing demand for our innovative technology.
We support companies navigating complex FDA and EMEA regulations, including 21 CFR Part 820, ISO 13485, and GAMP5. Our team of experienced professionals offers a comprehensive suite of services, from Design Validation and Equipment Qualification to Process Validation and Computerized System Validations.
CL Tech Inc. distinguishes itself through a commitment to meticulous detail, a deep understanding of risk management principles, and a proven track record of successfully resolving regulatory challenges and achieving zero audit findings. We provide both on-site and remote support, leveraging technology and expertise to ensure our clients meet the highest standards of quality and compliance.
We operate out of the Gateway University Research Park in Greensboro, collaborating with the Joint School of Nanoscience and Nanoengineering at North Carolina Agriculture and Technical State University and the University of North Carolina at Greensboro.
Kepley BioSystems is dedicated to developing rapid diagnostic tools, such as bloodstream infection detection, utilizing horseshoe crab blood, while prioritizing the species’ well-being and ensuring a reliable supply for the medical industry.
Founded in 2013 and supported by the National Science Foundation, we combine cutting-edge research with a commitment to ecological responsibility, driving disruptive innovations to achieve global solutions.
We focus on Tau protein dysregulation, a key driver of conditions like Alzheimer’s disease (AD), Frontotemporal dementia (FTD), and other tauopathies. Our mission is to prevent, delay, or mitigate the cognitive decline associated with these devastating disorders through the development of disease-modifying biotherapeutics.
By leveraging our Dual Intracellular and Extracellular Expression (dIEE) Technology, we’re pioneering a novel approach to target Tau at both the intracellular and extracellular levels, offering a potentially more effective strategy than previous treatments. We are committed to accelerating the development of these therapies and ultimately improving the lives of patients and families affected by tauopathies.
Innovative NeuroTechnologies, Inc. was recently awarded a Phase I SBIR grant from the National Institute of Health (NIH)/National Institute of Aging (NIA) and is nominated for the Los Angeles Business Journal’s 2015 Patrick Soon-Shiong Innovation Awards.
We support both established companies and emerging startups with a range of services, including concept and startup growth, expansion, ownership transition, and commercial operations.
AKDYS differentiates itself through a data-driven approach, combining market intelligence, business strategy development, and executive coaching to help clients navigate complex challenges and achieve their goals. We also provide architectural graphics services for commercial and residential home builders, leveraging our combined 25 years of design experience. Finally, we share our personal journey with mold toxicity through our ‘Mold Toxicity Battle’ blog, offering insights and resources for those affected by this often-overlooked condition.
Our team brings together decades of experience in technical, commercial, and leadership roles, dedicated to fostering health and creative design solutions.
We specialize in the design and development of gapmer therapeutics, utilizing artificial intelligence to create highly effective and targeted treatments. Our research is specifically geared towards addressing the global burden of HSV-1, particularly its impact on vision.
Viranova is committed to translating cutting-edge scientific discoveries into tangible solutions for patients suffering from debilitating viral infections. We are dedicated to advancing the field of antiviral therapeutics and improving patient outcomes through innovative, AI-driven drug development.
We empower researchers and innovators by delivering comprehensive support, from sourcing high-quality, USFDA- and CE-certified components like feeding tubes and syringes, to providing expert regulatory consulting for IVRT, IVPT, and BCS-based biowaiver studies.
Our strategic outsourcing services streamline study-to-submission journeys, offering end-to-end execution support, vendor coordination, and compliance-driven logistics. We’re dedicated to accelerating your research and development goals with precision and reliability.
Company Name | Location | Category | Employees | Accuracy | Website | |
|---|---|---|---|---|---|---|
Irvine, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | info@innocyto.com | http://www.innocyto.com | ||
Durham, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | info@trianglebio.com | http://www.trianglebio.com | ||
Irvine, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | info@xostem.com | https://xostem.com | ||
Chula Vista, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | info@exaltresearch.com | http://www.exaltresearch.com/ | ||
Lincoln, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | info@drjbthomas17.wixsite.com | https://drjbthomas17.wixsite.com/thepennycresscompany | ||
Research Triangle Park, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | info@helixomer.com | http://www.helixomer.com | ||
Irvine, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | info@hybrid-bio.com | http://www.hybrid-bio.com | ||
Durham, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | contact@upstreambiotech.com | http://www.upstreambiotech.com | ||
Hamden, United States (US) | Science and Engineering +1 Science and Engineering, Health and Medical | 2-10 | support@labvendor.com | https://www.labvendor.com/ | ||
Lincoln, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | info@mtebiotech.com | http://mtebiotech.com/ | ||
Greensboro, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | smdoliveira@ncat.edu | http://www.oliveiralab.me | ||
Durham, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | info@viamerbiosciences.com | http://www.viamerbiosciences.com | ||
St Petersburg, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | info@compliancelogix.com | http://www.compliancelogix.com | ||
Charleston, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | studysupport@cellseplabs.com | https://cellseplabs.com | ||
Lincoln, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | info@usedaro.com | http://usedaro.com | ||
Durham, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | info@dgenthera.com | https://www.dgenthera.com/ | ||
Chapel Hill, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | info@helpinghandproject.org | http://www.helpinghandproject.org/ | ||
Plano, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | info@starlightthera.com | http://starlightthera.com | ||
Durham, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | info@osteocuretx.com | http://osteocuretx.com | ||
Irvine, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | info@biotimesinc.com | https://www.biotimesinc.com/ | ||
Irvine, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | info@phaenobiotech.net | https://phaenobiotech.net | ||
Irvine, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | info@arvetasbio.com | https://arvetasbio.com | ||
Durham, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | info@muriphys.com | https://www.muriphys.com/ | ||
New Jersey, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | info@ateliermeats.com | https://www.ateliermeats.com/ | ||
Newport Beach, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | info@cavahealth.com | http://www.cavahealth.com | ||
Durham, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | info@eydisbio.com | http://www.eydisbio.com | ||
Durham, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | amesha.crudup@duke.edu | https://rtbaalas.wildapricot.org/ | ||
Orlando, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | info@usphytotherapy.com | http://www.usphytotherapy.com/ | ||
Durham, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | info@castagbio.com | http://www.castagbio.com | ||
Durham, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | info@neurospire.com | http://www.neurospire.com | ||
Durham, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | contact@vogenx.com | http://www.vogenx.com | ||
Irvine, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | info@vertical-longevity-pharma.com | https://vertical-longevity-pharma.com/ | ||
Durham, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | info@revivotherapeutics.com | https://revivotherapeutics.com | ||
Irvine, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | info@akhutherapeutics.com | http://akhutherapeutics.com | ||
Irvine, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | info@panlaboratories.com | http://www.panlaboratories.com | ||
Irvine, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | sales@biopico.com | http://www.biopico.com | ||
Newark, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | info@oculomotortechnologies.com | http://oculomotortechnologies.com | ||
Durham, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | info@nexosome-oncology.com | http://nexosome-oncology.com | ||
Durham, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | info@clinicalsensors.com | http://www.clinicalsensors.com | ||
Birmingham, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | info@tenurerecruiting.com | http://www.TenureRecruiting.com | ||
Irvine, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | info@cellechobio.com | http://www.cellechobio.com | ||
Irvine, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | sales@acgenetic.com | http://www.acgenetic.com | ||
Newark, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | info@bioneutralgroup.com | http://www.bioneutralgroup.com | ||
Durham, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | info@nabgen.com | http://www.nabgen.com | ||
Irvine, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | info@qeservices.weebly.com | https://qeservices.weebly.com/ | ||
GREENSBORO, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | info@kepleybiosystems.com | http://kepleybiosystems.com | ||
Irvine, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | info@innovneurotech.com | http://www.innovneurotech.com | ||
Research Triangle, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | info@akdys.com | https://akdys.com | ||
Irvine, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | info@viranova.bio | https://www.viranova.bio/ | ||
Gujarat, India | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | info@tpistos.com | http://www.tpistos.com |
50/859 results
Frequently asked questions
FAQ updated November 2025
What is Enterprise League?
Enterprise League is a business platform built for the doers, small businesses and startups who want to get seen, get leads, and grow.We help you showcase your company, connect directly with potential clients and partners, and get valuable insights into your performance, all without the middlemen or the fluff. Whether you're a team of 2 or 200, Enterprise League puts you on equal ground with the big players.
How can my business benefit from joining Enterprise League?
You get visibility, leads, and control, all in one place. Joining Enterprise League puts your business in front of thousands of verified companies. List your services, connect with decision-makers, and see real-time data on who’s visiting your profile.It’s a streamlined way to grow your presence, build partnerships, and stop relying on outdated directories or cold outreach.
What are the key features of Enterprise League?
Enterprise League gives you tools to grow faster: • Custom Profiles:Boos your visibility with a standout business profile. • Smart search: Get found by clients looking for your exact services. • Real analytics: See who's visiting, what's working and where you rank. • Direct messaging: Skip the cold emails and chat direct with prospects. • Reviews insights: Showcase real reviews and let AI highlight what matters. • Zero-fee marketplace: List and find products or services for free.
How does the company verification process work?
Get verified for the price of a coffee $0 Verified companies appear higher in search, build trust faster, and unlock an extra features. One badge. More business.
Can I try Enterprise League for free?
Absolutely. Our Free Plan is built for small businesses. You get profile visibility, marketplace access, and business directory use, free. Want more reach and features? Upgrade when you’re ready. No pressure.
How does the Interactive Business Directory work?
It’s like Google, but only for serious businesses. Search by location, size, or sector. Visit company profiles, send a message, or download insights. It’s built for real B2B decisions, not noise.
How can I download business insights?
Need competitor or market data? We’ve got it, and yes, you can download it. With our Business Insights Download feature, you can export detailed company and industry data in CSV format, including decision-makers, background info, and more. It’s perfect for sales targeting, market research, or just getting smarter about your next move.
What is the Referral Program?
Invite a business friend. You both get rewarded. Refer another company and when they join, you both get 1 month of Premium — free. It’s our way of growing the community with good people.
How does the Reviews feature work?
Show off your best reviews, without lifting a finger. We pull your reviews from Google, Facebook, Trustpilot and more. Then our AI highlights the most important insights. You just sit back and shine.
What plans are available?
Three simple plans: Free Plan: Get started with a verified profile, search access, and the ability to add products and services. Premium: More reach, more leads, deeper analytics. Ultimate: All the bells and whistles, including a dedicated growth partner.
How can my company win an award?
We highlight the best of the best, and that could be you. We run 50+ startup award categories every year. Apply for free. Winners get recognition, visibility, and bragging rights.